Cerity Partners’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-21,235
Closed -$3.32M 760
2020
Q4
$3.32M Buy
21,235
+746
+4% +$95.9K 0.11% 155
2020
Q3
$2.35M Buy
20,489
+11,603
+131% +$1.25M 0.1% 149
2020
Q2
$998K Buy
8,886
+10
+0.1% +$1.06K 0.06% 203
2020
Q1
$797K Sell
8,876
-2,615
-23% -$257K 0.05% 237
2019
Q4
$1.24M Sell
11,491
-4,093
-26% -$438K 0.06% 213
2019
Q3
$1.53M Sell
15,584
-2,018
-11% -$227K 0.09% 197
2019
Q2
$2.31M Sell
17,602
-1,939
-10% -$250K 0.15% 141
2019
Q1
$2.64M Sell
19,541
-87
-0.4% -$10.8K 0.18% 132
2018
Q4
$1.91M Sell
19,628
-692
-3% -$81.8K 0.13% 161
2018
Q3
$2.83M Buy
20,320
+554
+3% +$69.5K 0.2% 130
2018
Q2
$2.45M Sell
19,766
-1,644
-8% -$192K 0.18% 133
2018
Q1
$2.39M Sell
21,410
-2,563
-11% -$306K 0.18% 134
2017
Q4
$2.87M Sell
23,973
-2,791
-10% -$340K 0.19% 119
2017
Q3
$3.75M Buy
26,764
+20,084
+301% +$2.73M 0.27% 92
2017
Q2
$656K Buy
6,680
+4,861
+267% +$566K 0.05% 206
2017
Q1
$221K Buy
+1,819
New +$235K 0.02% 402

Other funds holding ALXN